BetterLife Pharma (BETRF) Change in Receivables (2014 - 2026)
BetterLife Pharma (BETRF) posted quarterly Change in Receivables of -$3727.0 for Q2 2026, down 288.27% year-over-year from $1979.6 in Q2 2025, and down 1226.7% quarter-over-quarter from -$280.93 in Q3 2025.
BetterLife Pharma (BETRF) Change in Receivables (2014 - 2026) Analysis & Trends
BetterLife Pharma's Change in Receivables history runs 10 years deep, the most recent figure standing at -$3727.0 for Q2 2026.
- In Q2 2026, Change in Receivables fell 288.27% year-over-year to -$3727.0; the TTM figure through Apr 2026 stood at -$5066.6 (down 150.97% YoY), while the FY2026 annual figure was $6341.0, down 67.75% from the prior year.
- Change in Receivables for Q2 2026 stood at -$3727.0, down from -$280.93 in the prior quarter.
- The five-year high for Change in Receivables was $247444.2 in Q2 2022, with the low at -$203856.9 in Q1 2022.
- The 5-year median for Change in Receivables is -$1298.1 (2023), against an average of $2689.5.
- The sharpest annual moves came in 2024 and 2026: Change in Receivables jumped 2045.88% in 2024, then sank 288.27% in 2026.
- BetterLife Pharma's Change in Receivables stood at -$9338.9 in 2022, then soared by 92.88% to -$664.48 in 2023, then surged by 2045.88% to $12930.0 in 2024, then plunged by 102.17% to -$280.93 in 2025, then sank by 1226.7% to -$3727.0 in 2026.
- Business Quant data shows BETRF's Change in Receivables at -$3727.0 in Q2 2026, -$280.93 in Q3 2025, and $1979.6 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | -3,727.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -3,727.05 |
| Apr 30, 2026 | -3,727.05 |
| Jul 31, 2025 | -280.93 |
| Jul 31, 2025 | -280.93 |
| Apr 30, 2025 | 1,979.59 |
| Apr 30, 2025 | 1,979.59 |
| Jan 31, 2025 | -3,038.19 |
| Jan 31, 2025 | -3,038.19 |
| Oct 31, 2024 | 12,930.02 |
| Oct 31, 2024 | 12,930.02 |
| Jul 31, 2024 | -1,931.68 |
| Jul 31, 2024 | -1,931.68 |
| Apr 30, 2024 | 12,694.20 |
| Apr 30, 2024 | 12,694.20 |
| Jan 31, 2024 | -19,757.22 |
| Jan 31, 2024 | -19,757.22 |
| Oct 31, 2023 | -664.48 |
| Oct 31, 2023 | -664.48 |
| Jul 31, 2023 | 17,920.96 |
| Jul 31, 2023 | 17,920.96 |